Pacira BioSciences, Inc. (PCRX): Cost of Revenue
$149.75M
Year ended 2025-12-31
$155.15M
Trailing 12 months to 2026-06-30
-9.1%
3-year compound annual growth
+5.0%
5-year compound annual growth
+7.6%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $149.75M | -12.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $170.43M | -7.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $184.67M | -7.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $199.29M | +42.1% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $140.25M | +19.5% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $117.33M | +9.9% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $106.71M | +22.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $86.84M | -1.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $87.92M | -20.2% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $110.10M | +53.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $71.84M | -7.2% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $77.44M | +41.4% | 2016-02-25, From 2014-01-01 |
| 2013-12-31 | $54.77M | +70.4% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $32.14M | +92.0% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $16.74M | +36.4% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $12.28M | -0.2% | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $12.30M | n/a | 2012-03-27, From 2009-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $149.75M | -12.1% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $363.83M | +1.6% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $74.56M | -4.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $326.20M | -52.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $12.98M | +19.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $77.67M | +27.5% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $317.31M | +24.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $100.71M | +161.7% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $198.34M | +26.5% |
Compare PCRX, AMPH, SUPN, EBS side by side · Screen every company in Pharmaceutical Preparations ↗